Biomarkes Of Job STRess In Emergency Senior Physicians - Detection of Stressful Events (JOBSTRESS)

December 28, 2023 updated by: University Hospital, Clermont-Ferrand

Biomarkers Of Job STRess In Emergency Senior Physicians - Detection of Stressful Events

Emergency medicine is a unique specialty focusing on a breadth of acute care, on demand . Shift work is also a fundamental component of emergency medicine, and is associated with chronic stress, including stress at work. Consequently, stress may lead to symptoms of mental exhaustion, physical fatigue, detachment from work, and feelings of diminished competence . Emergency physicians (EPs) are exposed to a complex interplay between stress (life-and-death emergencies - a defining characteristic of their job), sleep deprivation, and fatigue due to repeated changes in, and duration of shifts. Work-related exhaustion can lead to various physical and psychological symptoms, and also may be associated with delayed decision-making . The combined effects of stress and fatigue can impact on job performance, often resulting in otherwise preventable medical errors. Moreover, prolonged stress may expose EPs to a higher risk of multiple diseases, predominantly systemic inflammation and coronary heart disease. All these contribute to the premature departure of EPs to other specialties. Furthermore, low HRV has been associated with stress, burnout, and is linked with an increased risk of cardiovascular diseases.

This project proposes to evaluate if life-and-death emergencies or specific situations will induce abrupt changes in HRV among emergency physicians. Moreover, we would like to compare reactions between being an actor (EPs) and being a spectator and assess the role of expertise and habituation to stressful emergency situations.

Study Overview

Status

Completed

Detailed Description

The JOBSTRESS protocol was designed to provide a better understanding of the association between specific situations (ie: life and death emergencies) and breaks in the variability of the heart rate. Each emergency physician participates in the study two times. A night shift from 6:30 p.m to 8:30 a.m (14 hours) which will be compared with a day shift, as a control, from 8:30 a.m to 6:30 p.m. Emergency physicians will be accompanied by a medical externship student.

Statistical analysis will be performed using Stata software (version 13; Stata-Corp, College Station, Tex., USA). All statistical tests will be bilateral and a p <0.05 will be considered significant. Qualitative variables will be described in terms of numbers and proportions. Quantitative variables will be described in terms of numbers, average, median, standard deviation, and range. Graphic representations will be complete presentations of results. We process multivariate physiological series (HR, HRV, SC, wrist motion, respiratory rate) in order to build a stress index. For such multivariate physiological series, we first use change point analysis on each univariate series in order to get clusters with constant parameters, then we use classification algorithm on the constant parameters obtained in first step in order to obtain different classes corresponding to different levels of stress. Eventually, we obtain at each time the level of stress and can compare it to the environmental conditions.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France, 63003
        • CHU Clermont Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Emergency physicians from the emergency department of CHU Clermont-Ferrand will be accompanied by a medical externship student.
  • Ability to give a written informed consent.

Exclusion Criteria:

  • Participant refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Emergency physicians
actors during the work
Emergency will be followed during a night shift and the rest day et during a day shift and the rest day. They will be observed by a medical externship student. We will assess the role of expertise and habituation to stressful emergency situations.
Experimental: medical externship student
spectator during the emergency physician work
Emergency will be followed during a night shift and the rest day et during a day shift and the rest day. They will be observed by a medical externship student. We will assess the role of expertise and habituation to stressful emergency situations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
heart rate variability at night work
Time Frame: from 18:30 to 8:30, during the 14 hours of the night shift
measure of abrupt changes in HRV signals during 14 hours
from 18:30 to 8:30, during the 14 hours of the night shift
heart rate variability at day work
Time Frame: from 8:30 to 18:30, during the 10 hours of the day shift
measure of abrupt changes in HRV signals during 10 hours
from 8:30 to 18:30, during the 10 hours of the day shift

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Burnout
Time Frame: day 1
Burnout is assessed by the Maslach Burn-out Inventory (MBI) composed by 22 items and a 7-point scale ranging from "never" to "every day".
day 1
Depression
Time Frame: day 1
depression is assessed by the Hospital Anxiety and Depression scale (HAD) composed by 7 items and a 4-point scale from "never" to "always".
day 1
Anxiety
Time Frame: day 1
Anxiety is assessed by the the Hospital Anxiety and Depression scale (HAD) composed by 7 items and a 4-point scale from "never" to "always" and by the State-Trait Anxiety Inventory (STAI) composed by two dimensions, state anxiety and trait anxiety, both evaluated with a 20-items questionnaire on a 4-point scale from "never" to "always".
day 1
Lifestyle
Time Frame: day 1
Assessing factors regarding lifestyle are related to smoking, alcohol, coffee, food intake (questionnaires), and physical activity (Recent Physical Activity Questionnaire).
day 1
Life and occupational events
Time Frame: day 1
Assessing factors regarding death of patients or death of a loved one by questionnaire.
day 1
Sick leave
Time Frame: day 1
assessing sick leave by the number of absence days the previous 6 months using a questionnaire
day 1
Clinical measurements height
Time Frame: day 1
measure of height
day 1
Clinical measurements weight
Time Frame: day 1
measure of weight
day 1
Stress
Time Frame: 18:30, baseline of the night shift
measure of stress using VAS
18:30, baseline of the night shift
Fatigue
Time Frame: at 18:30, baseline of the night shift
measure of Fatigue using VAS
at 18:30, baseline of the night shift
Stress
Time Frame: at 8h30, at the end of the night shift
measure of stress using VAS
at 8h30, at the end of the night shift
Fatigue
Time Frame: at 8:30, at the end of the night shift
measure of Fatigue using VAS
at 8:30, at the end of the night shift
Stress
Time Frame: at 8:30, 24 hours after the end of night shift
measure of stress using VAS
at 8:30, 24 hours after the end of night shift
Fatigue
Time Frame: at 8:30, 24 hours after the end of night shift
measure of Fatigue using VAS
at 8:30, 24 hours after the end of night shift
Fatigue
Time Frame: at 18:30, 24 hours after the end of day shift
measure of Fatigue using VAS
at 18:30, 24 hours after the end of day shift
Stress
Time Frame: at 18:30, 24 hours after the end of day shift
measure of stress using VAS
at 18:30, 24 hours after the end of day shift
Stress
Time Frame: at 8:30, baseline of the day shift
measure of stress using VAS
at 8:30, baseline of the day shift
Fatigue
Time Frame: at 8:30, baseline of the day shift
measure of Fatigue using VAS
at 8:30, baseline of the day shift
Stress
Time Frame: at 18:30, end of the day shift
measure of stress using VAS
at 18:30, end of the day shift
Fatigue
Time Frame: at 18:30, end of the day shift
measure of Fatigue using VAS
at 18:30, end of the day shift
Saliva biomarkers cortisol
Time Frame: at 18:30, baseline of the night shift
measure of Cortisol
at 18:30, baseline of the night shift
Saliva biomarkers cortisol
Time Frame: at 8:30, at the end of the night shift
measure of Cortisol
at 8:30, at the end of the night shift
Saliva biomarkers cortisol
Time Frame: at 8:30, baseline of the day shift
measure of Cortisol
at 8:30, baseline of the day shift
Saliva biomarkers cortisol
Time Frame: at 18:30, end of the day shift
measure of Cortisol
at 18:30, end of the day shift
Saliva biomarkers DHEAS
Time Frame: at 18:30, baseline of the night shift
measure of DHEAS
at 18:30, baseline of the night shift
Saliva biomarkers DHEAS
Time Frame: at 8:30, at the end of the night shift
measure of DHEAS
at 8:30, at the end of the night shift
Saliva biomarkers DHEAS
Time Frame: at 8:30, baseline of the day shift
measure of DHEAS
at 8:30, baseline of the day shift
Saliva biomarkers DHEAS
Time Frame: at 18:30, end of the day shift
measure of DHEAS
at 18:30, end of the day shift
Saliva biomarkers lgAs
Time Frame: at 18:30, baseline of the night shift
measure of lgAs
at 18:30, baseline of the night shift
Saliva biomarkers lgAs
Time Frame: at 8:30, at the end of the night shift
measure of lgAs
at 8:30, at the end of the night shift
Saliva biomarkers lgAs
Time Frame: at 8:30, baseline of the day shift
measure of lgAs
at 8:30, baseline of the day shift
Saliva biomarkers lgAs
Time Frame: at 18:30, end of the day shift
measure of lgAs
at 18:30, end of the day shift
blood samples full blood count
Time Frame: at 8:30, at the end of the night shift
measure of full blood count
at 8:30, at the end of the night shift
blood samples full blood count
Time Frame: at 8:30, baseline of the day shift
measure of full blood count
at 8:30, baseline of the day shift
blood samples HbA1c,
Time Frame: at 8:30, at the end of the night shift
measure of HbA1c
at 8:30, at the end of the night shift
blood samples HbA1c,
Time Frame: at 8:30, baseline of the day shift
measure of HbA1c
at 8:30, baseline of the day shift
blood samples HDLc and LDL-cholesterol
Time Frame: at 8:30, at the end of the night shift
measure of HDLc and LDL-cholesterol
at 8:30, at the end of the night shift
blood samples HDLc and LDL-cholesterol
Time Frame: at 8:30, baseline of the day shift
measure of HDLc and LDL-cholesterol
at 8:30, baseline of the day shift
blood samples TG
Time Frame: at 8:30, at the end of the night shift
measure of TG
at 8:30, at the end of the night shift
blood samples TG
Time Frame: at 8:30, baseline of the day shift
measure of TG
at 8:30, baseline of the day shift
blood samples Cortisol
Time Frame: at 8:30, at the end of the night shift
measure of Cortisol
at 8:30, at the end of the night shift
blood samples Cortisol
Time Frame: at 8:30, baseline of the day shift
measure of Cortisol
at 8:30, baseline of the day shift
blood samples DHEAS
Time Frame: at 8:30, at the end of the night shift
measure of DHEAS
at 8:30, at the end of the night shift
blood samples DHEAS
Time Frame: at 8:30, baseline of the day shift
measure of DHEAS
at 8:30, baseline of the day shift
blood samples vitamine D
Time Frame: at 8:30, at the end of the night shift
measure of vitamine D
at 8:30, at the end of the night shift
blood samples vitamine D
Time Frame: at 8:30, baseline of the day shift
measure of vitamine D
at 8:30, baseline of the day shift
blood samples BDNF
Time Frame: at 8:30, at the end of the night shift
measure of BDNF
at 8:30, at the end of the night shift
blood samples BDNF
Time Frame: at 8:30, baseline of the day shift
measure of BDNF
at 8:30, baseline of the day shift
blood samples proinflammatory cytokines
Time Frame: at 8:30, at the end of the night shift
measure of proinflammatory cytokines
at 8:30, at the end of the night shift
blood samples proinflammatory cytokines
Time Frame: at 8:30, baseline of the day shift
measure of proinflammatory cytokines
at 8:30, baseline of the day shift
blood samples telomeres lengh
Time Frame: at 8:30, at the end of the night shift
measure of telomeres lengh
at 8:30, at the end of the night shift
blood samples telomeres lengh
Time Frame: at 8:30, baseline of the day shift
measure of telomeres lengh
at 8:30, baseline of the day shift
Life satisfaction
Time Frame: day 1
quality of life is assessed by a brief multidimensional life satisfaction scale (BMLSS)
day 1
diastolic blood pressure
Time Frame: at 18:30, baseline of the night shift
measure of diastolic blood pressure
at 18:30, baseline of the night shift
systolic blood pressure
Time Frame: at 18:30, baseline of the night shift
measure of systolic blood pressure
at 18:30, baseline of the night shift
diastolic blood pressure
Time Frame: at 8:30, at the end of the night shift
measure of diastolic blood pressure
at 8:30, at the end of the night shift
systolic blood pressure
Time Frame: at 8:30, at the end of the night shift
measure of systolic blood pressure
at 8:30, at the end of the night shift
diastolic blood pressure
Time Frame: at 8:30, baseline of the day shift
measure of disatolic blood pressure
at 8:30, baseline of the day shift
systolic blood pressure
Time Frame: at 8:30, baseline of the day shift
measure of systolic blood pressure
at 8:30, baseline of the day shift
diastolic blood pressure
Time Frame: at 18:30, end of day shift
measure of disatolic blood pressure
at 18:30, end of day shift
systolic blood pressure
Time Frame: at 18:30, end of day shift
measure of systolic blood pressure
at 18:30, end of day shift
skin conductance
Time Frame: from 18:30 to 8:30, during the 14 hours of night shift
measure of the skin conductance
from 18:30 to 8:30, during the 14 hours of night shift
skin conductance
Time Frame: from 8:30 to 18:30, during the 10 hours of day shift
measure of the skin conductance
from 8:30 to 18:30, during the 10 hours of day shift
Genetic factors ACE
Time Frame: at 8:30, end of the night shift
measure of the polymorphism of angiotensin converting enzyme inhibitors (ACE
at 8:30, end of the night shift
Genetic factors ACE
Time Frame: at 8:30, baseline of the day shift
measure of the polymorphism of angiotensin converting enzyme inhibitors (ACE
at 8:30, baseline of the day shift
Genetic factors (5-HTT)
Time Frame: at 8:30, end of the night shift
measure of the polymorphism of the serotonin transporter (5-HTT)
at 8:30, end of the night shift
Genetic factors (5-HTT)
Time Frame: at 8:30, baseline of the day shift
measure of the polymorphism of the serotonin transporter (5-HTT)
at 8:30, baseline of the day shift

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Frédéric Dutheil, University Hospital, Clermont-Ferrand

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 17, 2022

Primary Completion (Actual)

December 21, 2023

Study Completion (Actual)

December 21, 2023

Study Registration Dates

First Submitted

March 25, 2020

First Submitted That Met QC Criteria

April 1, 2020

First Posted (Actual)

April 6, 2020

Study Record Updates

Last Update Posted (Actual)

December 29, 2023

Last Update Submitted That Met QC Criteria

December 28, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • RBHP 2019 DUTHEIL 2
  • 2019-A02961-56 (Other Identifier: 2019-A02961-56)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Rate Variability

Clinical Trials on Comparison of biomarkers of stress

3
Subscribe